These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21994238)

  • 1. Prevention and treatment of doxorubicin-induced cardiotoxicity by dexrazoxane and schisandrin B in rabbits.
    Che F; Liu Y; Xu C
    Int J Toxicol; 2011 Dec; 30(6):681-9. PubMed ID: 21994238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Schisandrin B prevents doxorubicin-induced cardiotoxicity in rabbits].
    Che FF; Liu Y; Xu CG
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):24-8. PubMed ID: 20369464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention against and treatment of doxorubicin-induced acute cardiotoxicity by dexrazoxane and schisandrin B].
    Hu KY; Yang Y; He LH; Wang DW; Jia ZR; Li SR; Tian W; Mao J; Li XJ; Zhang W
    Yao Xue Xue Bao; 2014 Jul; 49(7):1007-12. PubMed ID: 25233631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schisandrin B prevents doxorubicin-induced cardiotoxicity via enhancing glutathione redox cycling.
    Li L; Pan Q; Han W; Liu Z; Li L; Hu X
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6753-60. PubMed ID: 18006777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac lesions induced by testosterone: protective effects of dexrazoxane and trimetazidine.
    Belhani D; Fanton L; Vaillant F; Descotes J; Manati W; Tabib A; Bui-Xuan B; Timour Q
    Cardiovasc Toxicol; 2009 Jun; 9(2):64-9. PubMed ID: 19484391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexrazoxane: how it works in cardiac and tumor cells. Is it a prodrug or is it a drug?
    Hasinoff BB; Herman EH
    Cardiovasc Toxicol; 2007; 7(2):140-4. PubMed ID: 17652819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats.
    Lebrecht D; Geist A; Ketelsen UP; Haberstroh J; Setzer B; Walker UA
    Br J Pharmacol; 2007 Jul; 151(6):771-8. PubMed ID: 17519947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats.
    Herman EH; Zhang J; Chadwick DP; Ferrans VJ
    Cancer Chemother Pharmacol; 2000; 45(4):329-34. PubMed ID: 10755322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits.
    Jirkovský E; Lenčová-Popelová O; Hroch M; Adamcová M; Mazurová Y; Vávrová J; Mičuda S; Šimůnek T; Geršl V; Štěrba M
    Toxicology; 2013 Sep; 311(3):191-204. PubMed ID: 23831762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective effect of dexrazoxane during treatment with doxorubicin: a study using low-dose dobutamine stress echocardiography.
    Paiva MG; Petrilli AS; Moisés VA; Macedo CR; Tanaka C; Campos O
    Pediatr Blood Cancer; 2005 Dec; 45(7):902-8. PubMed ID: 16035077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
    Seymour L; Bramwell V; Moran LA
    Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac protective effects of dexrazoxane on animal cardiotoxicity model induced by anthracycline combined with trastuzumab is associated with upregulation of calpain-2.
    Zhang S; Meng T; Liu J; Zhang X; Zhang J
    Medicine (Baltimore); 2015 Jan; 94(4):e445. PubMed ID: 25634181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of dexrazoxane for the prevention of anthracycline extravasation injury.
    Hasinoff BB
    Expert Opin Investig Drugs; 2008 Feb; 17(2):217-23. PubMed ID: 18230055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protective mechanism of schisandrin A in d-galactosamine-induced acute liver injury through activation of autophagy.
    Lu Y; Wang WJ; Song YZ; Liang ZQ
    Pharm Biol; 2014 Oct; 52(10):1302-7. PubMed ID: 24992201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death.
    Popelová O; Sterba M; Hasková P; Simůnek T; Hroch M; Guncová I; Nachtigal P; Adamcová M; Gersl V; Mazurová Y
    Br J Cancer; 2009 Sep; 101(5):792-802. PubMed ID: 19623174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles.
    Shao M; Yang W; Han G
    Int J Nanomedicine; 2017; 12():7121-7130. PubMed ID: 29026305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexrazoxane in the prevention of doxorubicin-induced cardiotoxicity.
    Seifert CF; Nesser ME; Thompson DF
    Ann Pharmacother; 1994 Sep; 28(9):1063-72. PubMed ID: 7803884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of schisandrin B against cyclosporine A-induced nephrotoxicity in vitro and in vivo.
    Zhu S; Wang Y; Chen M; Jin J; Qiu Y; Huang M; Huang Z
    Am J Chin Med; 2012; 40(3):551-66. PubMed ID: 22745070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats.
    Thompson KL; Rosenzweig BA; Zhang J; Knapton AD; Honchel R; Lipshultz SE; Retief J; Sistare FD; Herman EH
    Cancer Chemother Pharmacol; 2010 Jul; 66(2):303-14. PubMed ID: 19915844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schisandrin B attenuates acetaminophen-induced hepatic injury through heat-shock protein 27 and 70 in mice.
    Li L; Zhang T; Zhou L; Zhou L; Xing G; Chen Y; Xin Y
    J Gastroenterol Hepatol; 2014 Mar; 29(3):640-7. PubMed ID: 24219791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.